Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	85.93B -35.1%
Revenue (ttm)	32.16B +13.3%
Net Income	647.72M
EPS	75.61
Shares Out	8.41M
PE Ratio	135.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,336
Average Volume	42,451
Open	10,600.00
Previous Close	10,750.00
Day's Range	9,710.00 - 10,600.00
52-Week Range	9,120.00 - 21,500.00
Beta	0.90
RSI	38.91
Earnings Date	Mar 16, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.